EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Recurrent CAPN3 p.Asp753Asn Variant Supports a Potential Dominant Calpainopathy with Variable Clinical Expressivity

Giorgia D'Este iD, Alejandro Giorgetti iD, Denise Cassandrini, Francesca Magri, Dario Ronchi iD, Anna Rubegni, Diego Lopergolo iD, Alessandro Malandrini iD, Luciano Merlini iD, Gaetano Vattemi iD, Paola Tonin, Rita Barresi iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311384 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Giorgia D'Este und 11 weiteren Autor:innen. Beteiligte Einrichtung: Neurobiology Laboratory, San Camillo IRCCS, Via Alberoni 70, 30126 Venezia, Italy. Hauptthemen laut MEDLINE: Calpain, Muscular Dystrophies, Limb-Girdle, Muscle Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Limb-Girdle Muscular Dystrophies (LGMDs) are genetically heterogeneous disorders primarily affecting proximal limb muscles. The most common form, LGMDR1, results from biallelic CAPN3 mutations encoding calpain-3, a muscle-specific protease. Recently, growing evidence implicates heterozygous CAPN3 variants in autosomal dominant disease (LGMDD4), with pathogenic mechanisms still incompletely understood. In a retrospective multicenter Italian study of patients harboring monoallelic CAPN3 variants (ClinicalTrials.gov NCT05956132), the p.Asp753Asn substitution was the most frequent change, detected in eight unrelated individuals. These patients, aged 6–80 years, exhibited a spectrum of presentations ranging from asymptomatic hyperCKemia and exertional myalgia to mild proximal weakness. Muscle biopsies showed mild, nonspecific myopathic changes, while calpain-3 expression was variably reduced. Structural modeling suggested that Asp753 may stabilize the Ca2+-bound conformation, with substitution potentially disrupting inter-domain interactions. Literature review identified 31 additional reports worldwide, confirming recurrence while highlighting marked phenotypic heterogeneity and limited clinical annotation. The aggregated evidence supports a pathogenic role for p.Asp753Asn, though the precise mechanism, potentially involving a dominant-negative effect, remains to be validated. These findings emphasize diagnostic challenges posed by single CAPN3 variants and underscore the need for integrated clinical, segregation, and functional studies to clarify pathogenic mechanisms, refine counseling, and guide patient-specific rehabilitation and therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalpainMuscular Dystrophies, Limb-GirdleMuscle ProteinsHumansAdultAdolescentMaleMiddle AgedAgedFemaleChildYoung AdultAged, 80 and overMutationRetrospective StudiesPhenotype

Stichwörter der Autor:innen

CAPN3calpainopathydominant inheritancelimb-girdle muscular dystrophy

Substanzen

CalpainCAPN3 protein, humanMuscle Proteins

Autor:innen und Institutionen

  • Neurobiology Laboratory, San Camillo IRCCS, Via Alberoni 70, 30126 Venezia, Italy.
  • Department of Biotechnology, University of Verona, Strada Le Grazie 15, 37134 Verona, Italy.
  • UOC Immunologia, Azienda Ospedaliera Universitaria Integrata, P.le L.A. Scuro 10, 37134 Verona, Italy.
  • Department of Neurosciences, Biomedicine and Movement Sciences, Section of Clinical Neurology, University of Verona, Piazzale L.A. Scuro 10, 37134 Verona, Italy.
  • Neuromuscular Unit, IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 28, 20122 Milan, Italy.
  • Neurology Unit, IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

ORCID-Profile: Giorgia D'Este, Alejandro Giorgetti, Dario Ronchi, Diego Lopergolo, Alessandro Malandrini, Luciano Merlini, Gaetano Vattemi, Rita Barresi

Förderung

  • Ministero della Salute
  • Italian Ministry of Health

Zitieren

APA

D'Este, G., Giorgetti, A., Cassandrini, D., Magri, F., Ronchi, D., Rubegni, A., Lopergolo, D., Malandrini, A., Merlini, L., Vattemi, G., Tonin, P., & Barresi, R. (2025). Recurrent CAPN3 p.Asp753Asn Variant Supports a Potential Dominant Calpainopathy with Variable Clinical Expressivity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311384

Vancouver

D'Este G, Giorgetti A, Cassandrini D, Magri F, Ronchi D, Rubegni A, et al. Recurrent CAPN3 p.Asp753Asn Variant Supports a Potential Dominant Calpainopathy with Variable Clinical Expressivity. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311384

BibTeX
@article{DEste2025,
  author = {D'Este, Giorgia and Giorgetti, Alejandro and Cassandrini, Denise and Magri, Francesca and Ronchi, Dario and Rubegni, Anna and Lopergolo, Diego and Malandrini, Alessandro and Merlini, Luciano and Vattemi, Gaetano and Tonin, Paola and Barresi, Rita},
  title = {Recurrent CAPN3 p.Asp753Asn Variant Supports a Potential Dominant Calpainopathy with Variable Clinical Expressivity},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311384}
}
Kostenlos starten →